Current
4.8×
5-Year Average
7.7×
All-Time High
15.1×
All-Time Low
2.7×
P/B Ratio daily chart for Edwards Lifesciences (EW)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/B Ratio for Edwards Lifesciences (EW) from 2001 to 2025
| 2025 | $49.48B | $10.34B | 4.8× | +0.4× | |
| 2024 | $43.66B | $10.00B | 4.4× | -2.6× | |
| 2023 | $46.15B | $6.65B | 6.9× | -0.9× | |
| 2022 | $45.73B | $5.81B | 7.9× | -6.0× | |
| 2021 | $80.85B | $5.84B | 13.9× | +1.4× | |
| 2020 | $56.88B | $4.57B | 12.4× | +0.7× | |
| 2019 | $48.71B | $4.15B | 11.7× | +1.6× | |
| 2018 | $31.87B | $3.14B | 10.1× | +2.2× | |
| 2017 | $23.76B | $2.99B | 7.9× | +0.3× | |
| 2016 | $20.02B | $2.62B | 7.6× | +0.8× | |
| 2015 | $17.04B | $2.50B | 6.8× | +0.6× | |
| 2014 | $13.68B | $2.19B | 6.2× | +1.6× | |
| 2013 | $7.18B | $1.56B | 4.6× | -2.4× | |
| 2012 | $10.37B | $1.48B | 7.0× | +1.0× | |
| 2011 | $8.07B | $1.34B | 6.0× | -1.0× | |
| 2010 | $9.18B | $1.31B | 7.0× | +2.8× | |
| 2009 | $4.90B | $1.16B | 4.2× | +0.7× | |
| 2008 | $3.07B | $878.80M | 3.5× | +0.4× | |
| 2007 | $2.61B | $835.00M | 3.1× | -0.5× | |
| 2006 | $2.71B | $749.40M | 3.6× | +0.0× | |
| 2005 | $2.48B | $690.00M | 3.6× | -0.3× | |
| 2004 | $2.46B | $628.10M | 3.9× | +1.1× | |
| 2003 | $1.78B | $635.10M | 2.8× | +0.0× | |
| 2002 | $1.50B | $539.40M | 2.8× | -0.8× | |
| 2001 | $1.63B | $459.00M | 3.6× | — |
- 20254.8×
- 20244.4×
- 20236.9×
- 20227.9×
- 202113.9×
- 202012.4×
- 201911.7×
- 201810.1×
- 20177.9×
- 20167.6×
- 20156.8×
- 20146.2×
- 20134.6×
- 20127.0×
- 20116.0×
- 20107.0×
- 20094.2×
- 20083.5×
- 20073.1×
- 20063.6×
- 20053.6×
- 20043.9×
- 20032.8×
- 20022.8×
- 20013.6×
About P/B Ratio at Edwards Lifesciences (EW)
Edwards Lifesciences (EW) P/B ratio is 4.8× as of June 5, 2026. The 5-year average is 7.7×. The sector median currently stands at 3.4×. The current ratio is at the 28th percentile of its own 10-year history.
Edwards Lifesciences (EW) historical P/B ratio has ranged from a low of 2.7× (2002) to a high of 15.1× (2021) in the available daily series.
The price-to-book (P/B) ratio compares a company's market capitalisation to its book value of equity (total shareholders' equity) on the most recent quarterly balance sheet. It is calculated as market cap ÷ book value of equity (equivalent to share price ÷ book value per share). A P/B below 1× implies the market values the business below its accounting net worth; values well above 1× reflect intangible assets, brand value, or a high return on equity.
Edwards Lifesciences P/B Ratio by Year
Edwards Lifesciences P/B Ratio 2025: 4.8×
Edwards Lifesciences (EW) P/B ratio in 2025 was 4.8×, expanded from 4.4× the prior year.
Edwards Lifesciences P/B Ratio 2024: 4.4×
Edwards Lifesciences (EW) P/B ratio in 2024 was 4.4×, contracted from 6.9× the prior year.
Edwards Lifesciences P/B Ratio 2023: 6.9×
Edwards Lifesciences (EW) P/B ratio in 2023 was 6.9×, contracted from 7.9× the prior year.
Edwards Lifesciences P/B Ratio 2022: 7.9×
Edwards Lifesciences (EW) P/B ratio in 2022 was 7.9×, contracted from 13.9× the prior year.
Edwards Lifesciences P/B Ratio 2021: 13.9×
Edwards Lifesciences (EW) P/B ratio in 2021 was 13.9×.
Sector peers by P/B Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/B Ratio — table
Healthcare peers of Edwards Lifesciences (EW), ranked by P/B ratio.
| 2.9× | |
| 2.7× | |
| 2.6× | |
| 2.6× | |
| 2.5× | |
| 2.5× | |
| 2.4× | |
| 2.4× | |
| 2.3× | |
| 1.8× | |
| 1.8× | |
| 1.7× | |
| 1.7× | |
| 1.6× | |
| 1.5× | |
| 1.5× | |
| 1.5× | |
| 1.4× | |
| 1.4× | |
| 1.4× | |
| 1.2× | |
| 1.2× | |
| 1.1× | |
| 1.1× | |
| 0.8× |
- 2.7×
- 2.4×
- 2.3×
- 1.8×
- 1.7×
- 1.4×
- 1.4×
- 1.2×
- 1.1×
- 1.1×
- 0.8×
Frequently asked questions
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric